173 related articles for article (PubMed ID: 7555671)
1. [Immunogenicity and tolerance of a combined hepatitis A/B vaccine. Preliminary results with a candidate vaccine].
Kallinowski B; Bock HL; Clemens R; Theilmann L
Dtsch Med Wochenschr; 1995 Oct; 120(42):1426-9. PubMed ID: 7555671
[TBL] [Abstract][Full Text] [Related]
2. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
4. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
7. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
Frazer IH; Jones B; Dimitrakakis M; Mackay IR
Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
[TBL] [Abstract][Full Text] [Related]
10. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults.
Bruguera M; Bayas JM; Vilella A; Tural C; González A; Vidal J; Dal-Ré R; Salleras L
Vaccine; 1996 Oct; 14(15):1407-11. PubMed ID: 8994314
[TBL] [Abstract][Full Text] [Related]
12. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
13. [Seroconversion following immunization with a plasma-derived vaccine against hepatitis B: study of a 3-injection protocol (0, 1, 6 months) in Brazzaville (Congo)].
Taty-Taty R; Saliou P; Yala F; Couroucé AM; Arthaud ML; Nerelli B; Biendo M; Wassoumbou E
Bull Soc Pathol Exot; 1990; 83(2):155-8. PubMed ID: 2145083
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity, reactogenicity and adherence to a combined hepatitis A and B vaccine in illicit drug users.
Lugoboni F; Quaglio G; Pajusco B; Civitelli P; Romanò L; Bossi C; Spilimbergo I; Mezzelani P
Addiction; 2004 Dec; 99(12):1560-4. PubMed ID: 15585047
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.
Schiff GM; Sherwood JR; Zeldis JB; Krause DS
J Adolesc Health; 1995 Jan; 16(1):12-7. PubMed ID: 7742331
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.
Ambrosch F; Wiedermann G; André FE; Delem A; Gregor H; Hofmann H; D'Hondt E; Kundi M; Wynen J; Kunz C
J Med Virol; 1994 Dec; 44(4):452-6. PubMed ID: 7897380
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view.
Rieger MA; Hofmann F; Michaelis M
Int J Occup Med Environ Health; 2004; 17(3):379-91. PubMed ID: 15683159
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of an inactivated hepatitis A vaccine in Indian adults.
Das K; Jain A; Gupta RK; Kar P
Natl Med J India; 1999; 12(6):268-9. PubMed ID: 10732428
[TBL] [Abstract][Full Text] [Related]
20. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
